Consensus Philip Morris International, Inc.

Equities

PM

US7181721090

Tobacco

Real-time Estimate Cboe BZX Other stock markets 11:49:33 23/01/2026 pm IST			5-day change	1st Jan Change
171.84 ^USD	+1.05%		-0.91%	+7.26%

08:08pm	Philip Morris International Presents Data to US FDA Supporting Modified Risk Tobacco Product Designation for ZYN	MT
21/01	When America Starts to Feel Like a Risky Asset

Evolution of the Average Target: Philip Morris International, Inc.

Evolution of the Target Price: Philip Morris International, Inc.

Changes in Analyst Recommendations: Philip Morris International, Inc.

2b4db371e8ad2324462ef10f24639.nAlQ0iwWO8uAAEsURRqyhCycXFpz1CeFEOqIsJuAKZk.8UcDgnpwb6TXMR9WMGnE_l_7KR8i5HHxJdjq4sG5H__9exGEYXcKnchiIA~4e2fccd04f94104c3cb6979bc6033ef3

Analysts' recommendations: Philip Morris International, Inc.

20/01	Jefferies Downgrades Philip Morris International to Hold From Buy, Adjusts PT to $180 From $220	MT
20/01	Analyst recommendations: Intel, Philip Morris, Duolingo, Netflix, SanDisk…
26/11	JPMorgan Adjusts PT on Philip Morris International to $185 From $190, Maintains Overweight Rating	MT
17/11	Barclays Adjusts PT on Philip Morris International to $180 From $220, Maintains Overweight Rating	MT
04/11	Philip Morris International Inc. Approves Change in the Designation of Jacek Olczak to Group CEO PMI, Effective January 1, 2026	CI
03/11	Citic Securities Adjusts Philip Morris International Price Target to $165 From $185	MT
22/25/22	Philip Morris Set for 'Substantial' Growth Despite Zyn Concerns, Morgan Stanley Says	MT
22/25/22	Deutsche Bank Adjusts Price Target on Philip Morris International to $192 From $195	MT
22/25/22	Needham Adjusts Price Target on Philip Morris International to $190 From $195, Maintains Buy Rating	MT
22/25/22	Morgan Stanley Trims Price Target on Philip Morris International to $175 From $182, Keeps Overweight Rating	MT
22/25/22	Stifel Adjusts Price Target on Philip Morris International to $180 From $186, Maintains Buy Rating	MT
21/25/21	Philip Morris beats Q3 profit estimates, raises guidance	RE
21/25/21	(PM) Philip Morris Expects 2025 Adjusted EPS Range $7.46-$7.56, vs. FactSet Est of $7.52	MT
21/25/21	Wall Street Advances as Apple Hits Record High; Earnings Calendar in Focus	MT
20/25/20	Apple Helps Lift Equities Intraday as Markets Await This Week's Corporate Earnings	MT
08/25/08	Alert on Philip Morris inadvertently tagged to Picard Medical withdrawn	RE
08/25/08	Philip Morris urges FDA to recommend continued marketing of IQOS as modified risk product	RE
19/25/19	US FDA to Ease Requirements on Nicotine Pouch Makers Under New Pilot Program	MT
19/25/19	Exclusive-FDA nicotine pouch pilot to ease manufacturers' research burden, transcript shows	RE
22/25/22	Bernstein Adjusts Philip Morris International Price Target to $175 From $155	MT
04/25/04	KGI Securities Initiates Philip Morris International at Outperform With $188 Price Target	MT
30/25/30	Barclays Adjusts PT on Philip Morris International to $220 From $225, Maintains Overweight Rating	MT
18/25/18	Goldman Sachs Adjusts PT on Philip Morris International to $200 From $190, Maintains Buy Rating	MT
14/25/14	UBS Raises Price Target on Philip Morris International to $181 From $170, Neutral Rating Maintained	MT
10/25/10	Barclays Adjusts PT on Philip Morris International to $225 From $220, Maintains Overweight Rating	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
PHILIP MORRIS INTERNATIONAL, INC.			+6.07%
BRITISH AMERICAN TOBACCO P.L.C.			+4.78%
IMPERIAL BRANDS PLC			+15.01%
SMOORE INTERNATIONAL HOLDINGS LIMITED			+73.31%
GODFREY PHILLIPS INDIA LIMITED	-	-	-
PHILIP MORRIS CR	-		-7.81%
TURNING POINT BRANDS, INC.			+2.59%
Average			+15.66%
Weighted average by Cap.			+7.60%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

170.05USD

Average target price

180.38USD

Spread / Average Target

+6.07%

High Price Target

200.00USD

Spread / Highest target

+17.61%

Low Price Target

158.00USD

Spread / Lowest Target

-7.09%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Jefferies & Co.
JPMorgan Chase
Barclays
Citic Securities
Deutsche Bank Securities
Needham & Co.
Morgan Stanley
Stifel Nicolaus
Bernstein
KGI Securities
Goldman Sachs
UBS
Citigroup
Argus
BofA Securities
First Shanghai
SBG Securities
Consumer Edge
Societe Generale
Morningstar
Redburn
Credit Suisse
Piper Sandler
J.P. Morgan Chase
JPMORGAN	Celine Pannuti